Item 8.01 Other Events.

On February 18, 2022, Adagio Therapeutics, Inc. (the "Company") issued a press release entitled "Adagio Therapeutics Announces CEO Succession Plan." On February 22, 2022, the Company issued a press release entitled "Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates." The press releases are attached as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit
  No.       Description

99.1          Press release, dated February 18, 2022.

99.2          Press release, dated February 22, 2022.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses